HDAC inhibitors suppressed small cell lung cancer cell growth and enhanced the suppressive effects of receptor-targeting cytotoxins via upregulating somatostatin receptor II.

Sun, Lichun; He, Quanyong; Tsai, Cheguo; Lei, Jun; Chen, Jing; Vienna Makcey, Lily; Coy, David H

Sun, Lichun; He, Quanyong; Tsai, Cheguo; Lei, Jun; Chen, Jing; Vienna Makcey, Lily; Coy, David H.

Afiliação

Sun L; The Third Xiangya Hospital of Central South UniversityChangsha, China.
He Q; Department of Medicine, School of Medicine, Tulane Health Sciences CenterNew Orleans, LA 70112-2699, USA.
Tsai C; Shenzhen Tyercan Bio-pharm Co., Ltd.Shenzhen, China.
Lei J; The Third Xiangya Hospital of Central South UniversityChangsha, China.
Chen J; Department of Medicine, School of Medicine, Tulane Health Sciences CenterNew Orleans, LA 70112-2699, USA.
Vienna Makcey L; The Third Xiangya Hospital of Central South UniversityChangsha, China.
Coy DH; Business School, Hunan UniversityChangsha 410012, China.

Am J Transl Res ; 10(2): 545-553, 2018.

Article em En | MEDLINE | ID: mdl-29511449